Orexo strengthens its commercial knowhow and appoints Nikolaj Sørensen as Chief Commercial Officer
Uppsala, Sweden, September 16, 2011 - Orexo AB (STO: ORX) appoints Nikolaj Sørensen as Chief Commercial Officer effective October 1, 2011.
has extensive experience of the pharmaceutical industry and will be responsible for Orexo's commercial operations as well as development of the company's commercial strategies.
international commercial experience is a key asset in Orexo's
goal to develop, market and sell proprietary products.
will be reporting to the CEO and will be part of the company's executive management team.
Nikolaj Sørensen has a Master of Science in Business and Economics and previously worked at Pfizer where he was i.a. Director and Brand Team Leader for Pfizer's leading pain treatment product in Europe and Canada. At Pfizer, Nikolaj also worked as Head of Business Development and Director of Strategic Planning, acted as Business Area Director for primary care products, and as Managing Director and Chairman of the board for Pfizer AB.
In addition, Nikolaj has been a member of the Board of the Swedish Pharmaceutical Industry Association (LIF) for the past few years.
Prior to working at Pfizer, Nikolaj was a consultant at Boston Consulting Group (BCG), focusing on life science and among other he was the Project Leader for the merger of Pfizer and Pharmacia in the Nordic region.
is an exciting company that I have followed for several years.
The company has a very interesting product portfolio that provides a solid foundation for a commercial organization.
I look forward to developing and executing Orexo's strategy for sales and marketing of the company's own products," said Nikolaj Sørensen
has had a strong focus on commercial development since 2010 and we are particularly pleased that we have succeeded in recruiting Nikolaj Sørensen
to be in charge of commercial operations.
"I am very happy to welcome Nikolaj to Orexo's executive management team."
Press release - Orexo
strengthens its commercial knowhow and appoints Nikolaj Sørensen